Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion type Assertion NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_head.
- NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion description "[Therefore, targeting inflammation along with the newly identified targets, such as MMP10 and S100A15, represents promising therapeutic strategies to treat SCCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_provenance.
- NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion evidence source_evidence_literature NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_provenance.
- NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion SIO_000772 24029918 NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_provenance.
- NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion wasDerivedFrom befree-2016 NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_provenance.
- NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_assertion wasGeneratedBy ECO_0000203 NP1109954.RAev5rxAQgxKpMyfcNHBF5U6Rj2OCfNYa1lRqIFnSt-A0130_provenance.